Fouad Namouni
Förmögenhet: - $ per 2026-05-31
Förmögenhet: - $ per 2026-05-31
Fouad Namouni is currently an Independent Director at Vor Biopharma, Inc. since 2024.
Formerly, served as Independent Director at Aprea Therapeutics, Inc. from 2020 to 2022, Senior VP & Head-Oncology Development at Bristol Myers Squibb Co. from 2016 to 2020, and President-Research & Development at Blueprint Medicines Corp.
from 2020 to 2025.
Education includes graduate studies at Université de Paris XI Paris Sud and undergraduate studies at Université de Paris 5 René Descartes.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
VOR BIOPHARMA, INC. -.--% | 2026-06-11 | 0 ( -.--% ) | - $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| VOR BIOPHARMA INC. | Direktör/Styrelseledamot | 2024-04-30 |
| Företag | Position | Slut |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Teknisk/Vetenskaplig/F&U Direktör | 2025-10-01 |
| APREA THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2022-05-16 |
| BRISTOL-MYERS SQUIBB COMPANY | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Université de Paris XI Paris Sud
Université de Paris XI Paris Sud Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université de Paris 5 René Descartes
Université de Paris 5 René Descartes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Vor Biopharma, Inc.
Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Aprea Therapeutics, Inc.
Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån